» Articles » PMID: 25363294

Synchronous Colorectal Liver Metastasis: a Network Meta-analysis Review Comparing Classical, Combined, and Liver-first Surgical Strategies

Overview
Journal J Surg Oncol
Date 2014 Nov 4
PMID 25363294
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In recent years, the management of synchronous colorectal liver metastasis has changed significantly. Alternative surgical strategies to the classical colorectal-first approach have been proposed. These include the liver-first and combined resections approaches. The objectives of this review were to compare the short- and long-term outcomes for all three approaches.

Methods: A systematic review of comparative studies was performed. Evaluated endpoints included surgical outcomes (5-year overall survival, 30-day mortality, and post-operative complications). Pair-wise and network meta-analysis (NMA) were performed to compare survival outcomes.

Results: Eighteen studies were included in this review, reporting on 3,605 patients. NMA and pair-wise meta-analysis of the 5-year overall survival did not show significant difference between the three surgical approaches: combined versus colorectal-first, mean odds ratio (OR) 1.02 (95% CI 0.8-1.28, P = 0.93); liver-first versus colorectal-first, mean OR 0.81 (95% CI 0.53-1.26, P = 0.37); liver-first versus combined, mean OR 0.80 (95% CI 0.52-1.24, P = 0.41). In addition NMA of the 30-day mortality among the three approaches also did not observe statistical difference. Analysis of variance showed that mean post-operative complications of all approaches were comparable (P = 0.51).

Conclusion: There are considerable differences in the peri-operative management of synchronous CLM patients. This meta-analysis demonstrated no clear statistical surgical outcome or survival advantage towards any of the three approaches.

Citing Articles

Establishment and validation of predictive models by mutational and transcriptional factors for the prognosis of stage IV colorectal cancer patients with liver metastasis who undergo palliative surgery on primary tumors.

Shen S, Zhang X Transl Cancer Res. 2025; 14(1):225-239.

PMID: 39974400 PMC: 11833386. DOI: 10.21037/tcr-24-1183.


The role of ferroptosis in colorectal cancer and its potential synergy with immunotherapy.

Xia W, Lv Y, Zou Y, Kang Z, Li Z, Tian J Front Immunol. 2025; 15():1526749.

PMID: 39850905 PMC: 11754392. DOI: 10.3389/fimmu.2024.1526749.


Pushing boundaries: simultaneous minimal-invasive resection of complex colorectal liver metastases and its primary tumor.

Dittrich L, Raschzok N, Krenzien F, Saidy R, Plewe J, Moosburner S Surg Endosc. 2024; 39(1):401-408.

PMID: 39567401 DOI: 10.1007/s00464-024-11411-8.


Challenges and Opportunities for Precision Surgery for Colorectal Liver Metastases.

OConnell R, Hoti E Cancers (Basel). 2024; 16(13).

PMID: 39001441 PMC: 11240734. DOI: 10.3390/cancers16132379.


Surgical Resection in Colorectal Liver Metastasis: An Umbrella Review.

Milazzo M, Todeschini L, Caimano M, Mattia A, Cristin L, Martinino A Cancers (Basel). 2024; 16(10).

PMID: 38791928 PMC: 11120322. DOI: 10.3390/cancers16101849.